Summary Renal cell carcinoma (RCC) is one of the most frequent urological tumors and exhibits metabolic reprogramming alongside genetic mutations. RCC cells reprogram pathways involved in glucose, lipid, and amino acid metabolism to meet their energy and anabolic demands. In recent years, targeted drugs, immunotherapy,...
Han Wu, Xin-Xin Gan, Si-Yi Wang et al.· iScience· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.